New York, NY January 7, 2014 – Small Cap IR is initiating coverage and special profile on Surna Inc. (OTCQB: SRNA) engineers, manufactures and installs commercial agricultural equipment to indoor cannabis cultivation facilities.  The company acquires scalable operating companies in the cannabis sector and expands them by incorporating its proprietary grow technology and comprehensive support systems.  The company has a nine-person engineering team focused on developing improved indoor cultivation systems to avoid technological obsolescence, and creating advanced technologies intended to retool the cannabis industry.

All cannabis growers purchase lights, climate and dehumidification systems, and nutrients, which gives the company future avenues of additional growth.  The company has been acquisitive, and its long term goal is to dominate the infrastructure, growing, and support sides of the global legal cannabis industry.  The company’s entry into the legal marijuana business was through its July 2014 acquisition of Hydro Innovations, LLC.  Hydro Innovations was a leading designer, manufacturer and distributor of proprietary, state-of-the-art indoor climate control systems such as chillers, lights, reflectors and irrigation systems for cannabis and other indoor agriculture markets.  Now operating as a wholly owned subsidiary, Hydro Innovations offers a line of commercial and small business indoor agricultural equipment (www.hydroinnovations.com).

Watch the video on the home page of Surna’s website, this will give you a good idea of what they are accomplishing: http://surna.com/

Increasing Revenues
• Revenues increase 330% sequentially, reaching $1.2M for Q3 FY 2014.
• Revenues including recent acquisitions reached $1.8M for Q3 2014.
• Gross Margins for the year-to-date reached 40% for Q3 2014.

All successful companies have a common denominator. Good successful people are involved.

Tom Bollich, CEO - Mr. Bollich began his career as a Robotics Engineer, working with artificial intelligence.  In 2007 he co-founded Zynga, the online gaming company.  Zynga created games such as FarmVille, Draw Something and Words with Friends.

Tom Bollich is just one example of the management team with an impressive resume’ here. (See the analyst report for additional management and their experience)

Chart and fundamentals are telling us this week could be the start of a bull run for SRNA.

Analyst Gives $1.26 price target
Link to Analyst Report: http://smallcapir.com/wp-content/uploads/2015/01/SRNA-CR-IR-.pdf

Progressive Care, Inc. (OTCBB: RXMD) through its subsidiary PharmCo, LLC is a South Florida provider of prescription pharmaceuticals specializing in prescription pharmaceuticals, health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME") and the supply of prescription medications to long term care facilities.

The company recently reflected on the successes it achieved in 2014 and discussed its outlook and its goals for 2015. Get the details at the report you can read at this link: http://bit.ly/-RXMD-AnalystReport

Microelectronics Technology Co. (OTCBB: MELY) through the acquisition of Cloud Data Corporation is positioned to capitalize on the exponential growth of today’s technology market within Cloud Computing.

The company has announced a stock dividend for its preferred shareholders and updated concerned parties of its operations. You can read about these developments here: http://bit.ly/-MELY--AnalystReport

Discovery Minerals, Ltd. (OTCBB: DSCR) is an acquisition and development company that targets natural resource properties through its subsidiaries. These properties fall within two primary channels: precious metals/mining and industrial hemp. Discovery subsidiaries engage in activities that include the cultivation, product development, and distribution of industrial hemp; and gold, silver and precious metals.

To learn more and read full analyst report use following link: http://bit.ly/--DSCR--AnalystReport

Cellceutix, Inc. (OTCBB: CTIX) is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antimicrobial applications. The company has several drugs in the development and clinical trial stages.

The detailed report attached to the link gives descriptions of these drugs and updates the potential and progress of the products: http://bit.ly/-CTIX--AnalystReport

About Small Cap IR
An issuer of reports written by financial analysts who provide a straightforward assessment of the profiled company and have pledged to remain free of influence when writing research reports. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

For more information and services provided beyond this release please use contact information provided below.

Forward-Looking Disclaimer  
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.  

Compliance Procedure  
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.

A full disclaimer can be found by viewing the analyst report.
If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at editor@smallcapir.com. For any urgent concerns or inquiries please contact us at editor@smallcapir.com.

Source: Small Cap IR
Contact: editor@smallcapir.com

Pulse Evolution (CE) (USOTC:PLFX)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Pulse Evolution (CE).
Pulse Evolution (CE) (USOTC:PLFX)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Pulse Evolution (CE).